Michael Dickinson Selected Research

Michael Dickinson Research Topics

Disease

23	Neoplasms (Cancer) 04/2024 - 10/2009
15	Lymphoma (Lymphomas) 04/2024 - 10/2012
14	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2024 - 03/2006
10	B-Cell Lymphoma (Lymphoma, B Cell) 12/2023 - 01/2021
9	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2023 - 07/2010
7	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2024 - 11/2014
7	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 08/2023 - 05/2012
6	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2023 - 10/2009
6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 09/2013
5	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 02/2024 - 02/2023
4	Infections 12/2023 - 01/2017
4	Multiple Myeloma 01/2023 - 12/2011
4	Febrile Neutropenia 11/2021 - 02/2013
4	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 10/2020 - 08/2013
3	COVID-19 12/2023 - 01/2020
3	Thrombocytopenia (Thrombopenia) 08/2023 - 12/2018
3	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 10/2009
3	T-Cell Lymphoma (Lymphoma, T Cell) 01/2021 - 08/2013
2	cell-associated neurotoxicity 12/2023 - 10/2022
2	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 10/2022
2	Diarrhea 11/2021 - 12/2018
2	Neutropenia 01/2021 - 10/2018
1	Cognitive Dysfunction 04/2024
1	Communicable Diseases (Infectious Diseases) 12/2023
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2023
1	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 01/2023
1	Erdheim-Chester Disease 01/2023
1	Systemic Scleroderma (Systemic Sclerosis) 01/2023
1	Pulmonary Arterial Hypertension 01/2023
1	Leukemia 01/2022
1	Hyperbilirubinemia 11/2021
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2021
1	Fatigue 03/2021
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Pain (Aches) 12/2019

Drug/Important Bio-Agent (IBA)

14	Chimeric Antigen ReceptorsIBA 02/2024 - 11/2013
7	tisagenlecleucelIBA 01/2024 - 01/2022
7	axicabtagene ciloleucelIBA 01/2024 - 01/2022
6	Rituximab (Mabthera)FDA Link 03/2024 - 10/2012
5	Histone Deacetylase InhibitorsIBA 09/2023 - 08/2010
5	Azacitidine (5 Azacytidine)FDA Link 08/2023 - 04/2013
5	romidepsin (FK228)FDA Link 01/2017 - 12/2011
3	Brentuximab VedotinIBA 01/2022 - 01/2019
2	Agammaglobulinaemia Tyrosine KinaseIBA 02/2024 - 02/2023
2	Bispecific AntibodiesIBA 01/2024 - 01/2022
2	ibrutinibIBA 10/2023 - 01/2018
2	eltrombopag FDA Link 08/2023 - 12/2018
2	pembrolizumabIBA 01/2022 - 01/2021
2	glofitamabIBA 01/2022 - 12/2021
2	AntigensIBA 12/2021 - 11/2013
2	venetoclaxIBA 11/2021 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 11/2021 - 08/2010
2	DNA (Deoxyribonucleic Acid)IBA 04/2021 - 10/2018
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 01/2018
2	Bortezomib (Velcade)FDA Link 01/2018 - 12/2011
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2018 - 12/2011
2	Histones (Histone)IBA 09/2013 - 08/2010
2	PanobinostatIBA 09/2013 - 10/2009
1	Dihydrotachysterol (AT 10)IBA 03/2024
1	VaccinesIBA 12/2023
1	Antiviral Agents (Antivirals)IBA 12/2023
1	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2023
1	Phosphotransferases (Kinase)IBA 01/2023
1	VemurafenibIBA 01/2023
1	GlucocorticoidsIBA 01/2023
1	Receptor for Advanced Glycation End ProductsIBA 01/2023
1	dabrafenibIBA 01/2023
1	molibresibIBA 01/2023
1	anticentromere antibodyIBA 01/2023
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023
1	Vasodilator Agents (Vasodilators)IBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	AntibodiesIBA 12/2021
1	RO6870810IBA 11/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2021
1	Immune Checkpoint InhibitorsIBA 10/2021
1	Formaldehyde (Formol)FDA Link 10/2021
1	ParaffinIBA 10/2021
1	Vincristine (Oncovin)FDA LinkGeneric 01/2021
1	10-propargyl-10-deazaaminopterin FDA Link 01/2021
1	Prednisolone (Predate)FDA LinkGeneric 01/2021
1	COVID-19 VaccinesIBA 01/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	tazemetostatIBA 11/2020

Therapy/Procedure

39	Therapeutics 01/2024 - 03/2006
12	Drug Therapy (Chemotherapy) 04/2024 - 07/2010
12	Stem Cell Transplantation 11/2023 - 07/2010
3	Immunotherapy 10/2022 - 09/2017
2	Blood Component Removal (Apheresis) 01/2018 - 05/2012
2	Aftercare (After-Treatment) 01/2015 - 08/2012
1	Cognitive Training 04/2024
1	Critical Care (Surgical Intensive Care) 12/2023
1	Time-to-Treatment 12/2023
1	Autologous Transplantation 11/2023
1	Complementary Therapies (Alternative Medicine) 03/2021
1	Tai Ji (Tai Chi Chuan) 03/2021
1	Qigong (Qi Gong) 03/2021
1	Exercise Therapy (Therapy, Exercise) 03/2021
1	Activities of Daily Living (ADL) 12/2019